Suchergebnisse - "Stingeni, Luca"

PubPharm (11)

1

Comparison of Long-Term Effectiveness and Safety of Upadacitinib for Atopic Dermatitis Between Dupilumab-Exposed and Dupilumab-Naïve Patients

enthalten in: Clinical drug investigation | 2024

von Napolitano, M. | Ferrucci, S. | Foggia, L. | +6

2

A 52-week multicenter retrospective real-world study on effectiveness and safety of dupilumab in children with atopic dermatitis aged from 6 to 11 years

enthalten in: The Journal of dermatological treatment | 2023

von Patruno, C. | Fabbrocini, G. | Lauletta, G. | +49

3

A 52-week update of a multicentre Italian real-world experience on effectiveness and safety of dupilumab in adolescents with moderate-to-severe atopic dermatitis

enthalten in: Journal of the European Academy of Dermatology and Venereology : JEADV | 2023

von Stingeni, L. | Bianchi, L. | Antonelli, E. | +58

4

Dupilumab Treatment in Children Aged 6-11 Years With Atopic Dermatitis : A Multicentre, Real-Life Study

enthalten in: Paediatric drugs | 2022

von Napolitano, M. | Fabbrocini, G. | Neri, I. | +35

5

Patients Withdrawing Dupilumab Monotherapy for COVID-19-Related Reasons Showed Similar Disease Course Compared With Patients Continuing Dupilumab Therapy

enthalten in: Dermatitis : contact, atopic, occupational, drug | 2022

von Chiricozzi, A. | Di Nardo, L. | Talamonti, M. | +40

6

Dupilumab treatment induced similar improvements in signs, symptoms, and quality of life in adults with moderate-to-severe atopic dermatitis with baseline Eczema Area and Severity Index Score <24 or ≥24

enthalten in: Italian journal of dermatology and venereology | 2022

von Offidani, A. | Stingeni, L. | Neri, I. | +5

7

Atopic dermatitis in adolescents : Effectiveness and safety of dupilumab in a 16-week real-life experience during the COVID-19 pandemic in Italy

enthalten in: Dermatologic therapy | 2021

von Stingeni, L. | Hansel, K. | Antonelli, E. | +11

8

Effectiveness and Safety of Long-Term Dupilumab Treatment in Elderly Patients with Atopic Dermatitis : A Multicenter Real-Life Observational Study

enthalten in: American journal of clinical dermatology | 2021

von Patruno, C. | Fabbrocini, G. | Longo, G. | +35

9

Dupilumab and COVID-19 : What should we expect?

enthalten in: Dermatologic therapy | 2020

von Patruno, C. | Stingeni, L. | Fabbrocini, G. | +2

10

Effectiveness of dupilumab for the treatment of nummular eczema phenotype of atopic dermatitis in adults

enthalten in: Dermatologic therapy | 2020

von Patruno, C. | Stingeni, L. | Hansel, K. | +7